Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)
- 1 February 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (4) , 445-451
- https://doi.org/10.1016/j.amjcard.2004.10.008
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly PatientsAnnals of Internal Medicine, 2002
- Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary SyndromesCirculation, 2002
- Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary InterventionA Randomized Controlled TrialJAMA, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization InvestigationCirculation, 2002
- The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventionsJournal of the American College of Cardiology, 2002
- Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart diseaseJournal of the American College of Cardiology, 2001
- Are Patients With Renal Failure Good Candidates for Percutaneous Coronary Revascularization in the New Device Era?Circulation, 2000
- A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty Final results of the fluvastatin angiographic restenosis (FLARE) trialEuropean Heart Journal, 1999
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976